1. Home
  2. NLSP vs ARTW Comparison

NLSP vs ARTW Comparison

Compare NLSP & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • ARTW
  • Stock Information
  • Founded
  • NLSP 2015
  • ARTW 1956
  • Country
  • NLSP Switzerland
  • ARTW United States
  • Employees
  • NLSP N/A
  • ARTW N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • NLSP Health Care
  • ARTW Industrials
  • Exchange
  • NLSP Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • NLSP 12.4M
  • ARTW 9.3M
  • IPO Year
  • NLSP 2021
  • ARTW N/A
  • Fundamental
  • Price
  • NLSP $2.50
  • ARTW $2.27
  • Analyst Decision
  • NLSP
  • ARTW
  • Analyst Count
  • NLSP 0
  • ARTW 0
  • Target Price
  • NLSP N/A
  • ARTW N/A
  • AVG Volume (30 Days)
  • NLSP 411.8K
  • ARTW 33.4K
  • Earning Date
  • NLSP 07-15-2025
  • ARTW 07-15-2025
  • Dividend Yield
  • NLSP N/A
  • ARTW N/A
  • EPS Growth
  • NLSP N/A
  • ARTW N/A
  • EPS
  • NLSP N/A
  • ARTW 0.14
  • Revenue
  • NLSP N/A
  • ARTW $23,916,932.00
  • Revenue This Year
  • NLSP N/A
  • ARTW N/A
  • Revenue Next Year
  • NLSP N/A
  • ARTW N/A
  • P/E Ratio
  • NLSP N/A
  • ARTW $45.91
  • Revenue Growth
  • NLSP N/A
  • ARTW N/A
  • 52 Week Low
  • NLSP $1.30
  • ARTW $1.40
  • 52 Week High
  • NLSP $15.59
  • ARTW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 52.64
  • ARTW 67.32
  • Support Level
  • NLSP $2.16
  • ARTW $1.88
  • Resistance Level
  • NLSP $3.08
  • ARTW $2.42
  • Average True Range (ATR)
  • NLSP 0.24
  • ARTW 0.14
  • MACD
  • NLSP -0.00
  • ARTW 0.04
  • Stochastic Oscillator
  • NLSP 30.21
  • ARTW 78.26

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: